scPharmaceuticals's total assets for Q3 2024 were $125.07M, an increase of 91.07% from the previous quarter. SCPH total liabilities were $94.36M for the fiscal quarter, a 67.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.